Cancer Talk

News

Therapy Assessed in Roswell Park Preclinical Study May Facilitate, Simplify Regional Therapy for Melanoma

Melanoma is the fifth most common cancer in the U.S., and often recurs as multiple small tumors of the extremities. While these small tumors, called “in-transit” disease, can be treated through chemotherapy given directly to the affected limb, the standard for this focused or “regional” treatment has not been improved upon for more than 50 years. Preclinical research at Roswell Park Comprehensive Cancer Center demonstrates that the new anticancer drug CBL0137 is more effective than standard chemotherapy at killing melanoma tumor cells and was well tolerated in laboratory models. The study has been published online ahead of print in Cancer Research, a journal of the American Association for Cancer Research.
News

For Women with Breast Cancer, Higher Vitamin D Levels Associated with Improved Survival

A new study adds to the evidence that vitamin D can help fight some forms of cancer. The study, which was led by researchers at Roswell Park Comprehensive Cancer Center and Kaiser Permanente, shows that women with higher levels of vitamin D when diagnosed with breast cancer experienced longer cancer-free survival and were about 30% less likely to die from the disease.

Person sleeping in bed with alarm clock on bedside table
Article

Fall into a better night’s sleep

We are approaching that bittersweet time of year when we gain an hour of sleep but lose an hour of sunlight. At 2 a.m. on Sunday, November 6, most Americans will set their clocks back one hour as daylight saving time ends.
Life & Wellness
News

While Side Effects from Immunotherapy Remain Rare, It’s Important to Spot Them Quickly

Immunotherapy, which uses the body’s own immune system to fight disease, is transforming the treatment of several types of cancers. Severe adverse effects can result from these groundbreaking cancer treatments, however, and when they do, it’s important to recognize and quickly address them, researchers write in the New England Journal of Medicine.

News

Gov. Cuomo Announces Landmark Roswell Park Study Bringing Cuban Lung Cancer Vaccine to U.S. Patients, and Approval of Historic U.S. Government License Authorizing U.S.–Cuba Commercial Partnership to Fast-Track Biotech Development

Gov. Andrew Cuomo today announced that a partnership formed during his historic New York State Trade Mission to Cuba last year has resulted in a milestone of international collaboration: the launch of a U.S. clinical trial of a Cuban immunotherapy developed by the Center of Molecular Immunology (CIM) for lung cancer.